Coherus Oncology, Inc. Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders
Coherus Oncology, Inc. (CHRS) reported Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders of $2.13 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-25.
Discontinued › Noncontrolling Interest Items
us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders · last filed 2021-02-25
- Coherus Oncology, Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2018-09-30 was $18.00K.
- Coherus Oncology, Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2018-06-30 was $47.00K.
- Coherus Oncology, Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2018-03-31 was $5.00K.
- Coherus Oncology, Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2018 was $2.13M, a 1736.21% increase from fiscal 2017.
- Coherus Oncology, Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2017 was $116.00K, a 74.28% decline from fiscal 2016.
- Coherus Oncology, Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2016 was $451.00K, a 33.48% decline from fiscal 2015.
- Coherus Oncology, Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2015 was $678.00K, a 1440.91% increase from fiscal 2014.
| Period end | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 3 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 6 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 9 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 12 month |
|---|---|---|---|---|
| 2018-12-31 | $2.13M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $18.00K 10-Q · filed 2019-11-08 | $65.00K derived: sum of 2 quarters · filed 2019-11-08 | $70.00K derived: sum of 3 quarters · filed 2019-11-08 | |
| 2018-06-30 | $47.00K 10-Q · filed 2019-11-08 | $52.00K derived: sum of 2 quarters · filed 2019-11-08 | ||
| 2018-03-31 | $5.00K 10-Q · filed 2019-11-08 | |||
| 2017-12-31 | $116.00K 10-K · filed 2020-02-27 | |||
| 2016-12-31 | $451.00K 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $678.00K 10-K · filed 2018-03-08 | |||
| 2014-12-31 | $44.00K 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |